Courtney O'Konek | Senior Director, Corporate Communications & Investor Relations |
Mark Enyedy | President & Chief Executive Officer |
Anna Berkenblit | Chief Medical Officer |
Susan Altschuller | Chief Financial Officer |
Kristen Smith | Chief Commercial Officer |
John Newman | Canaccord Genuity |
Yige Guo | Guggenheim Securities |
Etzer Darout | BMO Capital Markets |
Boris Peaker | Cowen |
Andy Hsieh | William Blair & Company |
Kennan MacKay | RBC Capital Markets |
Jessica Fye | JPMorgan |
Earl DeSouza | H.C. Wainwright |
Joseph Catanzaro | Piper Sandler |
Jonathan Chang | SVB Leerink |
Good morning, ladies and gentlemen and welcome to ImmunoGen's Fourth Quarter and Full Year 2021 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications. Please go ahead.
Good morning and thank you for joining today's call.